top of page
  • Safi Bello

Acorda draws buyout interest from neuro-focused Biogen, UCB: report

Fierce Pharma ---------- Earlier this month, reports said Acorda could be scouting buyers. And now, rumors are swirling as to who those potential bidders might be. The Ardsley, New York-based drugmaker has attracted takeout interest from both Big Biotech Biogen and Belgium’s UCB, Bloomberg said. That interest fulfills a prophecy from Scopia Capital Management, an activist hedge fund that’s been pushing Acorda to sell. “We are highly confident that multiple qualified, potential buyers would be interested in engaging with Acorda,” Scopia wrote in a letter to Acorda’s board in August. To learn more click on the picture below to read the article.

Acorda draws buyout interest from neuro-focused Biogen, UCB: report - Read More from Fierce Pharma

0 views
Featured Posts
Recent Posts
Follow Us
  • Instagram
  • Pinterest
  • Tumblr Social Icon
bottom of page